Sunshine Biopharma Inc. Operating Leases, Rent Expense
Sunshine Biopharma Inc. (SBFM) reported Operating Leases, Rent Expense of $513 for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2020-11-12
- Sunshine Biopharma Inc. operating leases, rent expense for the quarter ending 2020-09-30 was $513.00, a 0.97% decline year-over-year.
- Sunshine Biopharma Inc. operating leases, rent expense for the quarter ending 2020-06-30 was $492.00, a 51.24% decline year-over-year.
- Sunshine Biopharma Inc. operating leases, rent expense for the quarter ending 2020-03-31 was $507.00, a 59.38% decline year-over-year.
- Sunshine Biopharma Inc. operating leases, rent expense for the quarter ending 2019-09-30 was $518.00, a 66.45% decline year-over-year.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month |
|---|---|---|---|
| 2020-09-30 | $513.00 10-Q · filed 2020-11-12 | $1.00K derived: sum of 2 quarters · filed 2020-11-12 | $1.51K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $492.00 10-Q/A · filed 2020-08-31 | $999.00 10-Q/A · filed 2020-08-31 | |
| 2020-03-31 | $507.00 10-Q · filed 2020-05-18 | ||
| 2019-09-30 | $518.00 10-Q · filed 2020-11-12 | $1.53K derived: sum of 2 quarters · filed 2020-11-12 | $2.77K 10-Q · filed 2020-11-12 |
| 2019-06-30 | $1.01K 10-Q/A · filed 2020-08-31 | $2.26K 10-Q/A · filed 2020-08-31 | |
| 2019-03-31 | $1.25K 10-Q · filed 2020-05-18 | ||
| 2018-09-30 | $1.54K 10-Q · filed 2019-11-13 | $3.58K derived: sum of 2 quarters · filed 2019-11-13 | $5.12K 10-Q · filed 2019-11-13 |
| 2018-06-30 | $2.04K 10-Q · filed 2019-08-15 | $3.57K 10-Q · filed 2019-08-15 | |
| 2018-03-31 | $23.06K 10-Q · filed 2018-05-22 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-16 | $0.00 derived: sum of 2 quarters · filed 2018-11-16 | $0.00 10-Q · filed 2018-11-16 |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-17 | $0.00 10-Q · filed 2018-08-17 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |